American Century Companies Inc Genmab A/S Transaction History

American Century Companies Inc

$168 Billion
Q4 2024

A detailed history of American Century Companies Inc transactions in Genmab A/S stock. As of the latest transaction made, American Century Companies Inc holds 320,575 shares of GMAB stock, worth $7.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

320,575

Previous 397,080 19.27%

Holding current value

$7.16 Million

Previous $9.68 Million 30.89%

% of portfolio

0.0%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$20.02 - $24.15 $1.53 Million - $1.85 Million	-76,505 Reduced 19.27%	320,575 $6.69 Million
Q3 2024 Nov 12, 2024	SELL	$23.84 - $28.48 $1.31 Million - $1.57 Million	-55,115 Reduced 12.19%	397,080 $9.68 Million
Q2 2024 Aug 07, 2024	SELL	$25.13 - $30.27 $320,332 - $385,851	-12,747 Reduced 2.74%	452,195 $11.4 Million
Q1 2024 May 14, 2024	BUY	$26.43 - $32.77 $225,183 - $279,200	8,520 Added 1.87%	464,942 $13.9 Million
Q4 2023 Feb 13, 2024	BUY	$27.94 - $35.44 $12.8 Million - $16.2 Million	456,422 New	456,422 $14.5 Million
Q3 2023 Nov 13, 2023	SELL	$35.27 - $42.24 $318,417 - $381,342	-9,028 Reduced 1.96%	450,508 $15.9 Million
Q2 2023 Aug 14, 2023	SELL	$37.4 - $42.94 $5.91 Million - $6.79 Million	-158,052 Reduced 25.59%	459,536 $17.5 Million
Q1 2023 May 11, 2023	BUY	$34.88 - $43.22 $251,449 - $311,572	7,209 Added 1.18%	617,588 $23.3 Million
Q4 2022 Feb 13, 2023	BUY	$33.8 - $47.06 $560,032 - $779,737	16,569 Added 2.79%	610,379 $25.9 Million
Q3 2022 Nov 14, 2022	SELL	$31.52 - $373.61 $294,396 - $3.49 Million	-9,340 Reduced 1.55%	593,810 $19.1 Million
Q2 2022 Aug 12, 2022	BUY	$26.83 - $38.57 $4.89 Million - $7.03 Million	182,311 Added 43.32%	603,150 $19.6 Million
Q1 2022 May 11, 2022	BUY	$30.95 - $39.68 $11.8 Million - $15.1 Million	381,013 Added 956.69%	420,839 $15.2 Million
Q4 2021 Feb 07, 2022	BUY	$35.87 - $47.12 $51,078 - $67,098	1,424 Added 3.71%	39,826 $1.58 Million
Q3 2021 Nov 10, 2021	BUY	$41.55 - $48.72 $374,199 - $438,772	9,006 Added 30.64%	38,402 $1.68 Million
Q2 2021 Aug 05, 2021	BUY	$32.88 - $44.57 $21,043 - $28,524	640 Added 2.23%	29,396 $1.2 Million
Q1 2021 May 14, 2021	BUY	$30.92 - $44.4 $268,478 - $385,525	8,683 Added 43.26%	28,756 $944,000
Q4 2020 Feb 12, 2021	BUY	$33.66 - $40.76 $245,549 - $297,344	7,295 Added 57.09%	20,073 $816,000
Q3 2020 Nov 13, 2020	BUY	$33.07 - $38.68 $10,714 - $12,532	324 Added 2.6%	12,778 $468,000
Q2 2020 Aug 13, 2020	BUY	$20.05 - $33.89 $249,702 - $422,066	12,454 New	12,454 $422,000

Others Institutions Holding GMAB

# of Institutions

246

Shares Held

61.3M

Call Options Held

159K

Put Options Held

38K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $14.7B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account

American Century Companies Inc Genmab A/S Transaction History